1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
AAIDF Research Grants Program is sponsored by American Academy of Implant Dentistry Foundation (AAIDF). This program provides limited support for meritorious dental implant research projects, including determining the feasibility of larger projects, developing and testing new techniques and procedures, conducting small clinical or animal research projects, and analyzing grant data.
Get alerted about grants like this
Save a search for “American Academy of Implant Dentistry Foundation (AAIDF)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
AAIDF Grants - American Academy of Implant Dentistry Are you a patient looking for information on dental implants? Visit our Patient Information site! AAID Foundation Research Grants Application Now Open - Deadline for Submissions: July 1, 2026 NOTE: AAIDF Research Grants are for researchers only.
No dental patients. Application Open Date: March 2, 2026 Submission Deadline: July 1, 2026 As part of its mission, the AAIDF provides grant funding to researchers who are discovering new and innovative ways to advance the field of Implant Dentistry. Through grant funding, researchers aim to discover and translate their findings into implant dentistry practice.
Download the 2026 Research Grants flyer AAIDF Research Grants Application Portal David Steflik Grant Application Jaclyn Chalmers, Steflik Grantee The David Steflik Memorial Student Research Grants are available to all dental students and those in post-graduate and residency programs. Dr. Steflik was a Researcher and Professor at the Medical College of Georgia in Augusta since 1979.
There he served as a Professor of Surgery and Director of Research for Orthopedic Surgery. He was also Professor of cell biology-anatomy in the School of Graduate Studies and held an appointment at the Department of Veteran Affairs Medical Center. Dr. Steflik's research on tissue responses to implanted biomaterials led to breakthroughs in dental implantology.
The AAIDF Steflik Grants are appropriate for new investigators, post-graduate students, and those resuming their research careers. Applicants may now request up to $7,000. 00 USD to fund their research project for up to a two-year grant period.
Applicants also have the opportunity to attend the AAID Annual Conference and present project findings once the research is complete, with reimbursement for travel costs up to $1,500. 00 USD starting in 2026. International students are welcome and encouraged to apply.
Please download and review the AAIDF Grant Guidelines Tool before starting the online application. Download the AAIDF Grant Guidelines Tool Note: This Grant is for dental students in post-graduate and residency programs only. No dental patients.
Research Grant Application The AAIDF Research Grants Program is intended to provide limited support for meritorious dental implant research projects which include, but are not limited to, the following purposes: To conduct research that determines the feasibility of a larger research project To develop and test new techniques and procedures To conduct small clinical or animal research projects Starting in 2026, applicants may request up to $32,500.
00 USD to fund a project for up to a two-year grant period. Successful applicants who require additional time to perform the proposed research may request a no-cost extension of the grant period without additional monetary support. Note: This Grant is for researchers in implant dentistry.
Funds are not awarded to dental patients. Download the AAIDF Grant Guidelines Tool Additional Forms and Application Tools Applicants will be required to complete an AAIDF Grants Budget Disclosure and Proposal Form as a part of the application process. This form includes information on allowable expenses, and expenses that are not within grant guidelines.
ALLOWABLE/NOT ALLOWABLE EXPENSES* • Small equipment purchases. • Salary for technical and support personnel. • The purchase of large pieces of equipment.
• Salary for the principal investigator and/or consultants.
Indirect costs refer to expenses that are not directly attributable to a specific project but are necessary for the overall operation and support of the organization; i.e. administrative salaries, office supplies or equipment, laptops, general travel (unless traveling to an AAID conference to present and requesting a reimbursement as a part of the Steflik grant award), accounting and legal services.
*You can download the form here or in the online program: Download the AAIDF Grants Budget Disclosure and Proposal Form AAIDF Grant Guidelines Tool Questions? You can download the following AAIDF Grant Guidelines Tool to help you complete your application. If you are still having trouble, send an e-mail to foundation@aaid.
com and a staff person will assist you. Download the AAIDF Grant Guidelines Tool Join the American Academy of Implant Dentistry Donate to the AAID Foundation Visit the Patient Information Site Membership & Account Access Whether you are an AAID member or not, we invite you to set up an online account to potentially: Access the Member Directory Receive Legislative Updates The members of AAID invite and encourage you to join!
By working together, we can achieve our mission to maintain and enhance our industry as a whole. Our sole intention is to uplift the profession of implant dentistry and to make it welcoming and accessible to all communities. View Membership Information
Based on current listing details, eligibility includes: Researchers in implant dentistry. Funds are not awarded to dental patients. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $32,500 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is July 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.